Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): Are we coming to a consensus?

Atherosclerosis Supplements

Volumn 12, Issue 2, 2011, Pages 217-220

  Humphries, Steve E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN;

APHERESIS; ATHEROSCLEROSIS; AUSTRALIA AND NEW ZEALAND; BELGIUM; CARDIOLOGIST; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONSENSUS DEVELOPMENT; CORONARY ARTERY CALCIFICATION; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DISEASE COURSE; ECHOGRAPHY; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC SCREENING; HUMAN; INFORMATION RETRIEVAL; LIFESTYLE; NETHERLANDS; PATIENT CARE; PATIENT IDENTIFICATION; PEDIATRICIAN; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SPAIN; SYSTEMATIC REVIEW (TOPIC); UNITED KINGDOM; UNITED STATES;

ADULT; ANTICHOLESTEREMIC AGENTS; AUSTRALASIA; CHILD; CHOLESTEROL, LDL; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; PRACTICE GUIDELINES AS TOPIC;

EID: 84855509659     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/S1567-5688(11)00037-7     Document Type: Editorial

References (25)

1. CG71 Familial hypercholesterolemia: NICE guideline 2008 http://guidance.nice.org.uk/CG71.
2. Wierzbicki AS, Humphries SE, Minhas R. Familial hypercholesterolemia: summary of NICE guidance. BMJ 2008;337:a1095.
3. Minhas R, Humphries SE, Qureshi N, Neil HA, NICE Guideline Development Group. Controversies in familial hypercholesterolemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolemia. Heart 2009;95(April (7)):584-7.
4. Goldberg AC, Hopkins PN, Toth PP, et al. National Lipid Association Expert Panel on familial hypercholesterolemia: screening, diagnosis and management of paediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on familial hypercholesterolemia. J Clin Lipidol 2011;5(June (3 Suppl.)):S1-8.
5. Descamps OS, Tenoutasse S, Stephenne X, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 2011;218(October (2)):272-80.
6. Watts GF, Sullivan DR, Poplawski N, et al. Familial hypercholesterolemia: a model of care for Australasia. Atherosclerosis Suppl 2011;12:217-59.
7. Marks D, Thorogood M, Neil HAW, et al. A review on the diagnosis, natural history and treatment of familial hypercholesterolemia. Atherosclerosis 2003;168(1):1-14.
8. Nherera L, Calvert NW, DeMott K, et al. Cost effectiveness analysis of the use of a high intensity statin compared to a low intensity statin in the management of patients with familial hypercholesterolemia. Curr Med Res Opin 2010;26(December (3)):529-36.
9. Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE. Probabilistic cost effectiveness analysis of cascade screening for familial hypercholesterolemia using alternative diagnostic and idenfication strategies. Heart 2011;97(July (14)):1175-81.
10. Starr B, Hadfield SG, Hutten BA, et al. Development of sensitive and specific age- and gender-specific low density lipoprotein cholesterol cut-offs for diagnosis of relatives with familial hypercholesterolemia in cascade testing. Clin Chem Lab Med 2008;46(6):791-803.
11. Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial hypercholesterolemia: a long term cohort study. BMJ 2008;337(November (11)):a2423.
12. Sivapalaratnam S, van Loendersloot LL, Hutten BA, Kastelein JJ, Trip MD, de Groot. Long-term LDL-C lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness. Atherosclerosis 2010 Oct;212(2):571-4.
13. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolemia in the Netherlands. Lancet 2001;357: 165-8.
14. Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993;72: 171-6.
15. Marks D, Wonderling D, Thorogood M, et al. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolemia. BMJ 2002;324:1303.
16. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolemia: screening strategy based on a meta-analysis. BMJ 2007;335(September 7620):599.
17. Miname MH, Ribeiro MS, 2nd, Parga Filho J, Avila LF, Bortolotto LA, Martinez LR, Rochitte CE, Santos RD. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis 2010;213(December (2)):486-91.
18. Sánchez-Bayle M, Soriano-Guillén L. Influence of dietary intervention on growth in children with hypercholesterolemia. Acta Paediatrica 2003;92(September (9)):1043-6.
19. Taylor A, Patel K, Tsedeke J, Humphries SE, Norbury G. Mutation screening in patients for familial hypercholesterolemia (ADH). Clin Genet 2010;77(January (1)):97-9.
20. Newson AJ, Humphries SE. Cascade testing in familial hypercholesterolemia: how should family members be contacted? Eur J Hum Genet 2005;13(4):401-8.
21. Thompson GR, Catapano A, Saheb S, et al. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe. Curr Opin Lipidol 2010;21:492-8.
22. Datta BN, McDowell IF, Rees A. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolemia. Curr Opin Lipidol 2010;21:366-71.
23. HEART UK. FH guideline implementation team toolkit; 2011. Available from www.heartuk.org.uk/FHToolkit.
24. Damgaard D, Larsen ML, Nissen PH, et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 2005;180(May (1)):155-60.
25. National Clinical Audit of the Management of Familial Hypercholesterolaemia 2010: FULL REPORT January 2011 http://www.rcplondon.ac.uk/resources/audits/FH.